Altered STAT4 Isoform Expression in Patients with Inflammatory Bowel Disease

Area of Science:

• Immunology
• Gastroenterology
• Molecular Biology

Background:

• Inflammatory bowel disease (IBD), including Crohn's disease (CD) and ulcerative colitis (UC), arises from complex genetic, environmental, and immune interactions.
• Signal Transducer and Activator of Transcription 4 (STAT4) is an IL-12-activated transcription factor implicated in immune responses.

Purpose of the Study:

• To investigate the expression of STAT4 isoforms (STAT4β/STAT4α) in pediatric patients with CD and UC.
• To determine if STAT4 isoform ratios can serve as biomarkers for IBD diagnosis and pathogenesis.

Main Methods:

• Biopsy and blood samples were collected from newly diagnosed CD and UC patients, and from patients experiencing flares or in remission.
• STAT4β/STAT4α mRNA ratios were analyzed in tissue and peripheral blood mononuclear cells.
• Expression of cytokines (TNFα, IFNγ, GM-CSF, IL-17) was measured using PCR and multiplex analysis.

Main Results:

• Increased STAT4β/STAT4α ratios were observed in specific gastrointestinal segments of CD and UC patients, correlating with inflammation severity and location.
• Elevated STAT4β/STAT4α ratios were also found in peripheral blood of CD and UC patients compared to healthy controls.
• No changes in STAT4 ratios were seen in eosinophilic esophagitis, and ratios normalized with steroid treatment in IBD patients.

Conclusions:

• STAT4 isoforms represent potential noninvasive biomarkers for diagnosing and monitoring inflammatory bowel disease.
• STAT4 isoform expression patterns may offer insights into the underlying pathogenesis of IBD.